Market Access Why 70% of pharma partnership spend misses patients Finding a start-up or building an app is the cheap part; combining capabilities into something that scales across markets is the expensive part.
Digital The real test for healthtech companies isn’t innovation – it... The Basel Area is increasingly becoming a convergence point where life sciences, advanced computing, and health technology intersect.
R&D Strategies for creating an ecosystem to support early-stage ... Learn how to foster growth for early-stage biotech companies through innovative ecosystem strategies and valuable CDMO collaborations
Digital Garbage in, garbage out: The hidden data crisis in pharma This hidden data crisis is the fundamental barrier to scaling AI in the life sciences sector.
Digital Consolidating Digital Health: Insights from Frontiers Health... Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights.
Market Access Medical start-ups must address the evolving risks of the FDA... Embarking on the journey of a medical start-up is like navigating a complex labyrinth, where the final prize is the coveted FDA approval.
News FDA clears Viridian's Tepezza rival for thyroid eye disease Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.